Safety and Efficacy in LPL-Deficient Subjects of AMT-011, an Adeno-Associated Viral Vector Expressing Human Lipoprotein Lipase [S447X]
Clinical trial NCT01109498 · UNKNOWN
Trial details
- NCT number
- NCT01109498
- Sponsor
- Amsterdam Molecular Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2013-06-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.